- Home
- CENT vs IBRX Comparison
CENT vs IBRX Comparison
Compare CENT & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENT
- IBRX
- Stock Information
- Founded
- CENT 1955
- IBRX 2014
- Country
- CENT United States
- IBRX United States
- Employees
- CENT N/A
- IBRX N/A
- Industry
- CENT Consumer Specialties
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CENT Consumer Discretionary
- IBRX Health Care
- Exchange
- CENT Nasdaq
- IBRX Nasdaq
- Market Cap
- CENT 2.4B
- IBRX 2.4B
- IPO Year
- CENT N/A
- IBRX N/A
- Fundamental
- Price
- CENT $34.44
- IBRX $2.87
- Analyst Decision
- CENT Strong Buy
- IBRX Strong Buy
- Analyst Count
- CENT 2
- IBRX 5
- Target Price
- CENT $42.50
- IBRX $11.40
- AVG Volume (30 Days)
- CENT 78.9K
- IBRX 10.1M
- Earning Date
- CENT 08-06-2025
- IBRX 08-11-2025
- Dividend Yield
- CENT N/A
- IBRX N/A
- EPS Growth
- CENT N/A
- IBRX N/A
- EPS
- CENT 1.87
- IBRX N/A
- Revenue
- CENT $3,155,810,000.00
- IBRX $31,222,000.00
- Revenue This Year
- CENT $0.42
- IBRX $567.98
- Revenue Next Year
- CENT $1.77
- IBRX $160.56
- P/E Ratio
- CENT $18.32
- IBRX N/A
- Revenue Growth
- CENT N/A
- IBRX 10238.41
- 52 Week Low
- CENT $31.97
- IBRX $1.83
- 52 Week High
- CENT $43.88
- IBRX $7.63
- Technical
- Relative Strength Index (RSI)
- CENT 42.44
- IBRX 49.40
- Support Level
- CENT $34.06
- IBRX $2.77
- Resistance Level
- CENT $34.78
- IBRX $3.24
- Average True Range (ATR)
- CENT 0.73
- IBRX 0.23
- MACD
- CENT -0.19
- IBRX -0.03
- Stochastic Oscillator
- CENT 13.87
- IBRX 19.74
About CENT Central Garden & Pet Company
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.